This is a new guideline from NICE advising that ciclosporin ophthalmic emulsion (Ikervis) can be used for treating dry eye disease that hasn't responded to artificial tears. It has an anti-inflammatory effect on the cornea and lacrimal gland. The marketing authorisation is for treating severe keratitis in adult patients with dry eye disease.
Latest posts by Louise Hudman (see all)
- Nice | Who should we be testing for cirrhosis? - October 3, 2016
- Nice | Non-alcoholic fatty liver disease NAFLD - August 26, 2016
- Evolocumab and Alirocumab for treating dyslipidaemia - August 25, 2016